Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Influenza Vaccines and Drugs Market Growing at a CAGR of 10.24% During 2017 to 2022 Says a Report at ReportsnReports.com
  • USA - English


News provided by

ReportsnReports

26 May, 2017, 07:00 IST

Share this article

Share toX

Share this article

Share toX

PUNE, India, May 26, 2017 /PRNewswire/ --

The Global Influenza Drugs and Vaccines Market 2016 - 2021 new report says rising awareness in relation to influenza virus, surging investment by companies in R&D and increasing number of immunization programmes organized by the government have been some of the factors backing the growth of Global Influenza Market.

Browse 2 Tables and 76 Figures, 10 Major Company Profiles, spread across 180 pages available at http://www.reportsnreports.com/reports/1010794-global-influenza-drugs-and-vaccines-market-by-drugs-zanamivir-oseltamivir-phosphate-peramivir-by-vaccine-trivalent-quadrivalent-analysis-by-region-by-country-opportunities-and-forecast-2016-2021-ia-japan.html.

According to research report, "Global Influenza Drugs and Vaccines Market - By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)", global market is projected to display a steady growth rate represented by a CAGR of 10.24% during 2017 - 2022, chiefly driven by increasing spending over various immunization programmes.

The report titled "Global Influenza Drugs and Vaccines Market - By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) has covered and analysed the potential of Global Influenza Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global influenza market. Additionally, the report also highlights key development and new drugs launched by various companies across the globe.

Order a Copy of research report at http://www.reportsnreports.com/purchase.aspx?name=1010794.

Company Profiles are GlaxoSmithKline, Sanofi Pasteur, Inc., CSL Limited, Astrazeneca, Protein Sciences Corporation, Serum Institute of India PvtLtd., Emergent Biosolutions, Emergent Biosolutions, BioCryst Pharmaceuticals.Inc., Alvogen

Scope of the Report

Global Influenza Market

  • (Actual Period: 2012-2016E, Forecast Period: 2017-2022)
  • By Segment Type: Influenza Vaccine Market, Influenza Drugs Market
  • By Vaccine Type: Trivalent, Quadrivalent
  • By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir

Regional Markets - North America, Europe, APAC, RoW

  • (Actual Period: 2012-2016E, Forecast Period: 2017-2022)
  • By Segment Type: Influenza Vaccine Market, Influenza Drugs Market
  • By Vaccine Type: Trivalent, Quadrivalent
  • By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir

Country Analysis - US, Canada, UK, Germany, France, Japan, China, India

  • (Actual Period: 2012-2016E, Forecast Period: 2017-2022)
  • By Segment Type: Influenza Vaccine Market, Influenza Drugs Market

Other Report Highlights

  • Market Dynamics - Trends, Drivers, Challenges
  • Pipeline Analysis
  • Company Analysis - Falvogen, Gilead Science and Bio Cryst

Related Reports: 

Influenza Vaccines Market in Top 5 European Countries to 2022 - Market Size, Development and Forecasts

Global Avian Influenza Vaccines Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Global Influenza Diagnostics Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Explore More Reports on Pharmaceuticals at http://www.reportsnreports.com/market-research/pharmaceuticals/.

About Us: 

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.


Contact:
Ritesh Tiwari
2nd Floor, Metropole Building,
Next to Inox Theatre,
Bund Garden Road, Pune - 411013.
Maharashtra, India.
+1-888-391-5441
[email protected]

Connect with Us:

LinkedIn: http://www.linkedin.com/company/reportsnreports

RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.